Showing 1 - 8 results of 8 for search 'Sergio Daniel Simon', query time: 0.04s Refine Results
  1. 1
    Comparison between Oncotype DX test and standard prognostic criteria in estrogen receptor positive early-stage breast cancer

    Comparison between Oncotype DX test and standard prognostic criteria in estrogen receptor positive early-stage breast cancer by Marcelo Roberto Pereira Freitas, Sergio Daniel Simon

    Published 2011-09-01
    Get full text
    Article
  2. 2
    Comparison between Oncotype DX test and standard prognostic criteria in estrogen receptor positive early-stage breast cancer

    Comparison between Oncotype DX test and standard prognostic criteria in estrogen receptor positive early-stage breast cancer by Marcelo Roberto Pereira Freitas, Sergio Daniel Simon

    Published 2011-09-01
    Get full text
    Article
  3. 3
    Gefitinib for patients with advanced non-small cell lung cancer treated on the expanded access program: a single institution experience

    Gefitinib for patients with advanced non-small cell lung cancer treated on the expanded access program: a single institution experience by Marcelo Rocha de Souza Cruz, Artur Katz, Rene Claudio Gansl, Jacques Tabacoff, Oren Smaletz, Sergio Daniel Simon

    Published 2006-09-01
    Get full text
    Article
  4. 4
    Imatinib improves survival of CML patients in accelerated phase: A 48-month follow-up

    Imatinib improves survival of CML patients in accelerated phase: A 48-month follow-up by Juliana Todaro, Euripides Ferreira, Nelson Hamerschlak, Sergio Daniel Simon, Jose Mauro Kutner, Marci Pietrocola, Cleide Largman Borovik

    Published 2006-03-01
    Get full text
    Article
  5. 5
    Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor

    Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor by Fabiana Viola, Jaques Tabacof, Rene Cláudio Gansl, Rober Abramoff, Artur Katz, Carlos Henrique Barrios, Sergio Daniel Simon

    Published 2008-09-01
    Get full text
    Article
  6. 6
    The impact of erlotinib use in non-small-cell lung cancer patients treated in a private reference general hospital and in a private cancer clinic from 2005 to 2011

    The impact of erlotinib use in non-small-cell lung cancer patients treated in a private reference general hospital and in a private cancer clinic from 2005 to 2011 by Cinthia Leite Frizzera Borges Bognar, Sergio Daniel Simon, Rene Claudio Gansl, Roberto Abramoff, Marcelo Aisen, Gilberto de Lima Lopes Junior, Oren Smaletz, Stela Verzinhasse Peres, Jacques Tabacof

    Get full text
    Article
  7. 7
    Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered

    Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered by Pedro Luiz Serrano Usón Junior, Monique Sedlmaier França, Heloisa Veasey Rodrigues, Antônio Luiz de Vasconcellos Macedo, Alberto Goldenberg, Oren Smaletz, Daniela Pezzutti Domingues Armentano, Sergio Daniel Simon, Rene Claudio Gansl

    Get full text
    Article
  8. 8
    Subgroup analysis of Brazilian participants of a medical leadership competencies instrument: a cross-sectional survey study of the Latin American Cooperative Oncology Group (LACOG) and the Academy of Leadership Sciences Switzerland (ALSS)

    Subgroup analysis of Brazilian participants of a medical leadership competencies instrument: a cross-sectional survey study of the Latin American Cooperative Oncology Group (LACOG)... by Max Senna Mano, Rafaela Gomes Jesus, Carlos Henrique Escosteguy Barrios, Wanessa Cassemiro Fernandes, Leandro Jonata de Carvalho Oliveira, Abna Faustina Sousa Vieira, Renan Orsati Clara, Antônio Luiz Frasson, Gustavo Nader Marta, Sérgio Daniel Simon, Cynthia Villarreal-Garza, Gustavo Werutsky, Fadil Çitaku

    Published 2022-12-01
    Get full text
    Article

Search Tools: